THE DOW SURGERY
WILLIAM STREET, REDDITCH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 13 | 14 | 92.9% | |
| HF 4 | 2011 | 11 | 11 | 100.0% | |
| HF 4 | 2012 | 23 | 28 | 82.1% | |
| HF 4 | 2013 | 22 | 27 | 81.5% | |
| HF004 | 2014 | 15 | 18 | 83.3% | |
| HF004 | 2015 | 10 | 12 | 83.3% | |
| HF004 | 2016 | 15 | 17 | 88.2% | |
| HF004 | 2017 | 24 | 27 | 88.9% | |
| HF004 | 2018 | 22 | 28 | 78.6% | |
| HF004 | 2019 | 24 | 28 | 85.7% | |
| HF004 | 2020 | 22 | 27 | 81.5% | |
| HF006 | 2021 | 31 | 38 | 81.6% | |
| HF006 | 2022 | 32 | 32 | 100.0% | |
| HF006 | 2023 | 27 | 28 | 96.4% |
